These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36860098)

  • 61. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history - an open-label randomised trial (the EPPI trial): study protocol.
    Groom KM; McCowan LM; Stone PR; Chamley LC; McLintock C;
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):367. PubMed ID: 27876004
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial.
    Rey E; Garneau P; David M; Gauthier R; Leduc L; Michon N; Morin F; Demers C; Kahn SR; Magee LA; Rodger M
    J Thromb Haemost; 2009 Jan; 7(1):58-64. PubMed ID: 19036070
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Placental Abnormalities and Placenta-Related Complications Following
    Kong F; Fu Y; Shi H; Li R; Zhao Y; Wang Y; Qiao J
    Front Endocrinol (Lausanne); 2022; 13():924070. PubMed ID: 35846290
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: A stratified cohort study.
    Zhang Y; Shen F; Yang W; Wang J; Zhou J; Chen Y
    Int J Gynaecol Obstet; 2021 Aug; 154(2):337-342. PubMed ID: 33314052
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study.
    Kosar A; Kasapoglu B; Kalyoncu S; Turan H; Balcik OS; Gümüs EI
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):14-8. PubMed ID: 21042205
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: a prospective pilot study.
    Conserva V; Muggiasca M; Arrigoni L; Mantegazza V; Rossi E; Ferrazzi E
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1467-73. PubMed ID: 22122225
    [TBL] [Abstract][Full Text] [Related]  

  • 70. T2*-weighted placental magnetic resonance imaging: a biomarker of placental dysfunction in small-for-gestational-age pregnancies.
    Hansen DN; Sinding M; Petersen A; Christiansen OB; Uldbjerg N; Peters DA; Frøkjær JB; Sørensen A
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100578. PubMed ID: 35114424
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants.
    Heazell AE; Hayes DJ; Whitworth M; Takwoingi Y; Bayliss SE; Davenport C
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012245. PubMed ID: 31087568
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study.
    Abbattista M; Gianniello F; Novembrino C; Clerici M; Artoni A; Bucciarelli P; Capecchi M; Peyvandi F; Martinelli I
    Lancet Haematol; 2020 Apr; 7(4):e320-e328. PubMed ID: 32112716
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?
    Mousa HA; Alfirevic1 Z
    Hum Reprod; 2000 Aug; 15(8):1830-3. PubMed ID: 10920112
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy.
    Alguel G; Vormittag R; Simanek R; Kyrle PA; Quehenberger P; Mannhalter C; Husslein P; Pabinger I
    Thromb Haemost; 2006 Sep; 96(3):285-9. PubMed ID: 16953268
    [TBL] [Abstract][Full Text] [Related]  

  • 76. ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.
    de Jong PG; Quenby S; Bloemenkamp KW; Braams-Lisman BA; de Bruin JP; Coomarasamy A; David M; DeSancho MT; van der Heijden OW; Hoek A; Hutten BA; Jochmans K; Koks CA; Kuchenbecker WK; Mol BW; Torrance HL; Scheepers HC; Stephenson MD; Verhoeve HR; Visser J; de Vries JI; Goddijn M; Middeldorp S
    Trials; 2015 May; 16():208. PubMed ID: 25947329
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Placental pathology in fetal thrombophilia.
    Ariel I; Anteby E; Hamani Y; Redline RW
    Hum Pathol; 2004 Jun; 35(6):729-33. PubMed ID: 15188139
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA].
    Neikova K ; Dimitrova V; Dimitrov R; Savov A
    Akush Ginekol (Sofiia); 2015; 54(5):3-12. PubMed ID: 26411189
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review.
    Ray JG; Laskin CA
    Placenta; 1999 Sep; 20(7):519-29. PubMed ID: 10452905
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inherited thrombophilia and pregnancy complications revisited.
    Rodger MA; Paidas M; McLintock C; Middeldorp S; Kahn S; Martinelli I; Hague W; Rosene Montella K; Greer I
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):320-4. PubMed ID: 18669729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.